Antonio Mirijello

Department of Medical Sciences, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.

50 publications 2020 – 2026 ORCID

What does Antonio Mirijello research?

Dr. Mirijello studies various health conditions, particularly how they relate to cardiovascular risk and mental health. His research investigates how factors like resilience can help mitigate depression and anxiety in patients with inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. He also delves into the effectiveness of different diagnostic tools, like transthoracic ultrasound, for identifying conditions like spontaneous pneumothorax in emergency settings. Additionally, he explores treatment strategies for alcohol use disorder, emphasizing personalized approaches that target brain chemistry to improve recovery outcomes.

Key findings

  • Patients with Crohn's disease who had high resilience experienced 72.6% fewer depressive symptoms and 66.8% fewer anxiety symptoms.
  • In a study of 994 heart disease patients, each one-point increase in the Fibrosis-4 index raised the risk of death by more than double.
  • The RCHADS-VASc score was found to increase the likelihood of three-vessel coronary disease by 21% for each additional point.
  • Among heavy drinkers, nearly 46.5% reduced their alcohol consumption over six months, leading to significant improvements in heart function.
  • In a multicenter trial, patients using sodium oxybate experienced an average of 43.1 more days of sobriety compared to those taking a placebo.

Frequently asked questions

Does Dr. Mirijello study alcohol use disorders?
Yes, he researches various treatment options for alcohol use disorder, focusing on personalized approaches that improve patient sobriety.
What is the importance of Dr. Mirijello's research on inflammatory bowel diseases?
His work highlights how resilience can play a crucial role in reducing depression and anxiety in patients suffering from inflammatory bowel diseases, improving their overall mental health.
How does Dr. Mirijello's research help patients at high cardiovascular risk?
His studies provide valuable insights into predictive scoring systems that help healthcare providers identify patients at risk for severe heart issues, allowing for targeted monitoring and intervention.
What diagnostic tools does Dr. Mirijello evaluate for use in emergencies?
He studies the effectiveness of transthoracic ultrasound for diagnosing spontaneous pneumothorax in emergency settings, helping doctors make better diagnostic decisions.
What treatments has Dr. Mirijello found effective for patients with alcohol dependence?
He supports using medications like sodium oxybate in combination with psychological strategies to enhance treatment effectiveness for alcohol dependence.

Publications in plain English

Markedly raised CA 19-9 levels in an asymptomatic patient: the role of Helicobacter pylori infection.

2026

Minerva gastroenterology

D'Agruma A, D'Agruma L, Piscitelli P, Parente P, Graziano P +5 more

PubMed

The Fibrosis-4 index predicts all-cause mortality in a cohort of patients at high cardiovascular risk partly through glomerular filtration rate reduction.

2025

Nutrition, metabolism, and cardiovascular diseases : NMCD

Mirijello A, Pacilli G, Siena A, Mangiacotti A, D'Errico MM +7 more

Plain English
This study looked at the Fibrosis-4 index (FIB-4), a test used to evaluate liver health, and how it relates to the risk of dying in patients with high heart disease risk. Researchers followed 994 patients for about four years and found that those who later died had a higher initial FIB-4 score (1.71) compared to those who survived (1.38). For every point increase in the FIB-4 index, the chance of dying increased significantly (by more than double), and one-third of this increased risk was linked to kidney function decline. Who this helps: This research benefits doctors and patients with heart disease by providing a clearer tool to assess mortality risk.

PubMed

Clinical presentation of celiac disease in adult patients: current real‑life experience: comment.

2025

Internal and emergency medicine

Mirijello A, d'Angelo C, Pacilli G, Piscitelli P, De Cosmo S

PubMed

The role of resilience in mitigating depression and anxiety in patients with inflammatory bowel diseases.

2025

Journal of psychosomatic research

Ferrarese D, Vecchione M, Spagnolo G, Mirijello A, Di Vincenzo F +11 more

Plain English
This study examined how resilience, or the ability to cope with stress, affects depression and anxiety in patients with inflammatory bowel diseases (IBD) like Crohn's disease and ulcerative colitis. Researchers found that patients with higher resilience reported fewer symptoms of depression and anxiety; for example, in Crohn's patients, those with high resilience experienced 72.6% fewer depressive symptoms and 66.8% fewer anxiety symptoms. This matters because it highlights the importance of building resilience as a way to improve mental health in IBD patients, especially when their disease is more active. Who this helps: This helps patients with inflammatory bowel diseases and their healthcare providers.

PubMed

Current treatments of alcohol use disorder.

2024

International review of neurobiology

Dionisi T, Di Sario G, De Mori L, Spagnolo G, Antonelli M +8 more

Plain English
This research looked at the various treatments for Alcohol Use Disorder (AUD) and found that a mix of biological and psychological strategies is essential for effective care. It highlighted new approaches targeting brain chemicals like Glutamate, which may help patients reduce alcohol use, and emphasized the need for personalized treatment based on individual factors, given the high number of people affected globally. Overall, the research suggests that tailored therapies can significantly improve outcomes for those struggling with alcohol dependence. Who this helps: This helps patients with Alcohol Use Disorder and healthcare providers in designing effective treatment plans.

PubMed

Association between RCHADS-VASc score and three-vessel coronary artery disease in a large population at high cardiovascular risk.

2024

Internal and emergency medicine

Pacilli G, Piscitelli P, D'Errico MM, Mangiacotti A, Siena A +6 more

Plain English
This study looked at how the RCHADS-VASc score, which assesses cardiovascular risk, relates to severe coronary artery disease in over 1,000 patients at high risk. The researchers found that patients with three-vessel coronary disease had an average RCHADS-VASc score of 4.20 compared to 3.36 in those without it, and the risk of three-vessel disease increased by 21% for each additional point in the score. This matters because using the RCHADS-VASc score can help doctors identify patients who are at high risk of severe heart issues and target those who may need closer monitoring and intervention. Who this helps: This helps doctors and patients at high risk for heart disease.

PubMed

Low Diagnostic Accuracy of Transthoracic Ultrasound for the Assessment of Spontaneous Pneumothorax in the Emergency Setting: A Multicentric Study.

2024

Journal of clinical medicine

Quarato CMI, Mirijello A, Bocchino M, Feragalli B, Lacedonia D +15 more

Plain English
This study examined how effective transthoracic ultrasounds (TUS) are at diagnosing spontaneous pneumothorax (PNX) in emergency departments. Out of 637 patients who showed symptoms, TUS accurately identified PNX in 83 out of 93 cases, giving it a sensitivity of 89.2%. However, it also incorrectly suggested PNX in 306 patients who didn't actually have it, leading to a low specificity of 43.8%. This means while TUS is good at detecting PNX when it’s present, it often fails to rule it out when it’s not, so doctors should confirm findings with a chest X-ray or CT scan. Who this helps: This helps doctors in emergency departments make better diagnostic decisions for patients with chest pain.

PubMed

Identification and management of acute alcohol intoxication.

2023

European journal of internal medicine

Mirijello A, Sestito L, Antonelli M, Gasbarrini A, Addolorato G

Plain English
This paper looks at acute alcohol intoxication, which can be very dangerous and even life-threatening due to excessive alcohol consumption. It highlights that severe cases can lead to serious health issues such as breathing difficulties, unconsciousness, and heart problems. The study emphasizes the importance of stabilizing patients in emergency departments and suggests using a drug called metadoxine to help speed up the removal of alcohol from the body. It also points out the need to assess whether these patients may have ongoing alcohol dependency issues for further treatment. Who this helps: This helps patients struggling with alcohol use and medical professionals treating them.

PubMed

Treatment of acute alcohol intoxication: The role of metadoxine.

2023

European journal of internal medicine

Mirijello A, Addolorato G

PubMed

Contrast-Enhanced Ultrasound in Distinguishing between Malignant and Benign Peripheral Pulmonary Consolidations: The Debated Utility of the Contrast Enhancement Arrival Time.

2023

Diagnostics (Basel, Switzerland)

Quarato CMI, Feragalli B, Lacedonia D, Rea G, Scioscia G +8 more

Plain English
This study looked at how well a special ultrasound technique, called contrast-enhanced ultrasound (CEUS), can tell the difference between cancerous (malignant) and non-cancerous (benign) lung lesions. Researchers included 317 patients and found that the ultrasound method did not effectively distinguish between the two; it had an accuracy rate of just 47.6% and a sensitivity of only 5.3%. This is important because it shows that CEUS is not reliable for diagnosing lung issues, and traditional chest CT scans are still needed for accurate assessment. Who this helps: This helps doctors determine the best methods for diagnosing lung lesions in patients.

PubMed

A Review on Biological Effects of Ultrasounds: Key Messages for Clinicians.

2023

Diagnostics (Basel, Switzerland)

Quarato CMI, Lacedonia D, Salvemini M, Tuccari G, Mastrodonato G +6 more

Plain English
This study looked at how ultrasound (US) interacts with human tissues, particularly focusing on its effects on sensitive organs and developing embryos. Researchers found that while ultrasound is generally considered safe, there are specific risks linked to new ultrasound technologies, such as contrast-enhanced ultrasound and certain imaging techniques. This matters because understanding these risks helps doctors make safer decisions about using ultrasound, ensuring that patients are better protected during diagnostic procedures. Who this helps: This helps patients undergoing ultrasound procedures and their healthcare providers.

PubMed

Thoracic ultrasound combined with low-dose computed tomography may represent useful screening strategy in highly exposed population in the industrial city of Taranto (Italy).

2023

Frontiers in medicine

Quarato CMI, Dama E, Maggi M, Feragalli B, Borelli C +31 more

Plain English
This study looked at using thoracic ultrasound (TUS) as an initial screening tool for people living in a highly polluted area of Taranto, Italy, to see if they had lung problems or cancer. Among 677 participants, 24.7% agreed to a follow-up scan, and out of those, 50.9% had lung abnormalities. This is important because it shows that combining TUS with low-dose CT scans can help detect early signs of lung diseases and cancers in people who are at high risk due to environmental pollution. Who this helps: This benefits patients living in polluted areas who may be at risk for lung issues.

PubMed

Albuminuria improves RCHADS-VASc score in predicting mortality in high cardiovascular risk population.

2023

Nutrition, metabolism, and cardiovascular diseases : NMCD

Piscitelli P, D'Errico MM, Vigna C, Marchese N, Lamacchia O +5 more

Plain English
This study looked at how well a new scoring system, called Alb-RCHADS-VASc, predicts death in people at high risk for heart problems compared to the existing RCHADS-VASc score. It found that adding albuminuria, a protein in urine that indicates kidney issues, to the score significantly improves its accuracy. Specifically, a one-point increase in the Alb-RCHADS-VASc score raises the risk of death by about 1.5 times, and those in the highest risk group had a 9.5-fold increased chance of dying. Who this helps: This information benefits doctors and healthcare providers working with patients who have cardiovascular risk factors.

PubMed

Abdominal Lymphadenopathies: Lymphoma, Brucellosis or Tuberculosis? Multidisciplinary Approach-Case Report and Review of the Literature.

2023

Medicina (Kaunas, Lithuania)

Mirijello A, Ritrovato N, D'Agruma A, de Matthaeis A, Pazienza L +10 more

Plain English
This study looked at a patient suffering from abdominal pain, fever, fatigue, and weight loss, who turned out to have an abdominal mass. Imaging tests and laboratory results pointed towards an infection rather than cancer, specifically linking it to brucellosis in a patient with latent tuberculosis. After a team of specialists discussed the findings, the patient had surgery to remove the mass, and with treatment, their symptoms improved. Who this helps: This helps doctors by highlighting the importance of a collaborative approach for diagnosing complex abdominal issues.

PubMed

Identifying Predictors Associated with Risk of Death or Admission to Intensive Care Unit in Internal Medicine Patients with Sepsis: A Comparison of Statistical Models and Machine Learning Algorithms.

2023

Antibiotics (Basel, Switzerland)

Mirijello A, Fontana A, Greco AP, Tosoni A, D'Agruma A +5 more

Plain English
This study looked at how to predict which patients with sepsis are at a higher risk of dying or needing to be admitted to an intensive care unit. Researchers examined 148 patients and found that 25% faced severe outcomes. Key predictors included the SOFA score and alertness levels, with certain models showing high accuracy in predicting risk—some even achieving an accuracy rating of 0.978, indicating they were very effective. Who this helps: This research benefits doctors and healthcare providers who care for patients with sepsis, helping them better identify those at risk.

PubMed

Transthoracic ultrasound shear wave elastography for the study of subpleural lung lesions.

2022

Ultrasonography (Seoul, Korea)

Quarato CMI, Venuti M, Dimitri L, Lacedonia D, Simeone A +8 more

Plain English
This study looked at a new ultrasound technology called shear wave elastography (SWE) to see if it can help doctors understand subpleural lung lesions, which are found near the outer surface of the lungs. Researchers tested 190 patients with these lesions and found that SWE could not reliably tell the difference between cancer and pneumonia, with no significant differences in stiffness measurements (P=0.296). However, they did find that pneumonia showed higher stiffness than cancer when necrotic lesions were excluded, which could influence treatment choices. Who this helps: This research benefits doctors by providing clearer insights into using SWE for diagnosing lung conditions.

PubMed

Low eGFR and albuminuria independently predict all-cause mortality in high-risk subjects undergoing coronary arteriography.

2022

Internal and emergency medicine

D'Errico MM, Piscitelli P, Mirijello A, Santoliquido M, Massa V +6 more

Plain English
This study looked at how kidney problems affect the risk of dying in patients who were undergoing a heart procedure called coronary arteriography. Out of 1,017 participants, 114 died over about 44 months. It found that individuals with low kidney function (eGFR under 60) were nearly three times more likely to die than those with normal kidney function, while those with albumin in their urine faced similar increased risks, highlighting the serious consequences of kidney issues in these patients. Who this helps: This helps patients undergoing heart procedures, especially those with kidney issues.

PubMed

Low GFR amplifies the association between coronary three-vessel disease and all-cause mortality.

2022

Nutrition, metabolism, and cardiovascular diseases : NMCD

Piscitelli P, D'Errico MM, Mirijello A, Santoliquido M, Salvatori M +6 more

Plain English
This study looked at how three-vessel disease (3VD), a severe heart condition, affects the risk of death in patients with chronic kidney disease (CKD). Out of 1,017 patients analyzed, those with both 3VD and low kidney function had nearly four times the risk of death compared to those without these conditions. This finding emphasizes that poor kidney health significantly increases the mortality risk for heart patients, underscoring the importance of managing kidney disease to improve outcomes. Who this helps: This helps patients with heart disease and kidney problems, as well as their doctors.

PubMed

Signs of Dissociation and Symptoms of Post-Traumatic Stress Disorder in Inflammatory Bowel Disease: A Case-Control Study.

2022

Digestive diseases (Basel, Switzerland)

Ferrarese D, Spagnolo G, Vecchione M, Scaldaferri F, Armuzzi A +6 more

Plain English
This study looked at how common post-traumatic stress disorder (PTSD) and dissociative symptoms are in patients with inflammatory bowel disease (IBD) compared to healthy people. It found that IBD patients had much higher rates of these symptoms—about 40% experienced PTSD compared to only 10% in the healthy group—and those with Crohn's disease showed more symptoms when their disease was active. Understanding these psychological symptoms is important because they can impact the overall health and treatment of IBD patients. Who this helps: This helps patients with inflammatory bowel disease and their doctors.

PubMed

Remdesivir significantly reduces SARS-CoV-2 viral load on nasopharyngeal swabs in hospitalized patients with COVID-19: A retrospective case-control study.

2022

Journal of medical virology

Biancofiore A, Mirijello A, Puteo MA, Di Viesti MP, Labonia M +4 more

Plain English
This study looked at how well the antiviral drug remdesivir reduces the amount of the COVID-19 virus in the noses of hospitalized patients. Researchers found that patients who received remdesivir had a viral load decrease of about 34.3, compared to 27.2 in those who did not receive the drug, showing that remdesivir significantly speeds up the reduction of the virus. This is important because lowering the viral load can lead to better outcomes for patients with COVID-19. Who this helps: This helps hospitalized COVID-19 patients.

PubMed

Factors Associated with Delirium in COVID-19 Patients and Their Outcome: A Single-Center Cohort Study.

2022

Diagnostics (Basel, Switzerland)

Di Giorgio A, Mirijello A, De Gennaro C, Fontana A, Alboini PE +13 more

Plain English
This study looked at 214 hospitalized patients with COVID-19 in Italy to understand how often delirium occurs and its effects on their health. It found that 22% of these patients, or 47 individuals, experienced delirium, which greatly increased their risk of dying or needing intensive care. Specifically, the study highlighted that those with hypoactive delirium faced a higher risk of serious outcomes compared to those with hyperactive delirium. Who this helps: This helps patients with COVID-19 and their doctors by identifying risk factors and prompting early interventions to reduce the likelihood of delirium and improve outcomes.

PubMed

Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy.

2022

Seminars in liver disease

Tarli C, Mirijello A, Addolorato G

Plain English
This study looked at how to treat people with alcohol use disorder (AUD) who also have liver problems caused by alcohol, known as alcohol-associated liver disease (ALD). It found that stopping alcohol use is crucial because continuing to drink leads to more severe health issues, such as a higher risk of death and the need for liver transplants. Despite the seriousness of the problem, standard medicines tested for AUD often exclude patients with ALD, making it unclear which treatments work best for them. Who this helps: This information benefits patients struggling with alcohol use and liver disease, as well as their doctors.

PubMed

Extraosseous effects of vitamin D: a role in the prevention and treatment of COVID-19?

2022

Internal and emergency medicine

Mirijello A, Piscitelli P, d'Angelo C, Tosoni A, De Cosmo S

PubMed

Adult anaphylaxis: To the heart of the matter.

2022

European journal of internal medicine

Mirijello A, De Cosmo S

PubMed

The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990-2019: Findings from the Global Burden of Disease Study 2019.

2022

The Lancet regional health. Europe

Castelpietra G, Knudsen AKS, Agardh EE, Armocida B, Beghi M +109 more

Plain English
This study looked at mental health issues, substance use, and self-harm among young people aged 10 to 24 in 31 European countries from 1990 to 2019. In 2019, there were about 17,000 cases of mental disorders, nearly 4,000 cases of substance use disorders, and about 89 cases of self-harm per 100,000 young people. The findings highlight a significant increase in certain disorders like eating disorders and drug use, especially in countries with fewer resources, showing that young people's mental health needs urgent attention and support. Who this helps: This helps patients, particularly young people facing mental health challenges.

PubMed

Echocardiographic markers of early alcoholic cardiomyopathy: Six-month longitudinal study in heavy drinking patients.

2022

European journal of internal medicine

Mirijello A, Sestito L, Lauria C, Tarli C, Vassallo GA +9 more

Plain English
This study looked at the heart health of heavy drinkers over six months to understand early signs of alcoholic cardiomyopathy (ACM), a heart condition caused by excessive alcohol use. Researchers examined 43 patients and found that nearly half (46.5%) reduced their alcohol consumption during treatment. Initially, some heart measurements were higher than normal, indicating potential issues, but those who cut back on drinking saw significant improvement in their heart function after six months. Who this helps: This helps patients struggling with alcohol dependence and their doctors.

PubMed

CHA2DS2-VASc and R2CHA2DS2-VASc scores predict mortality in high cardiovascular risk population.

2022

European journal of clinical investigation

D'Errico MM, Piscitelli P, Mirijello A, Santoliquido M, Salvatori M +7 more

Plain English
This study looked at two scoring systems, CHADS-VASc and RCHADS-VASc, to see how well they predict the risk of death in people with high heart disease risk. Researchers followed 1,017 patients who were at risk for heart problems and found that, for each point increase in either score, the risk of death increased by about 50%. The RCHADS-VASc score was shown to be better than the CHADS-VASc score in predicting mortality, making it a more reliable tool for doctors. Who this helps: This benefits doctors and healthcare providers who care for patients at high risk for heart disease.

PubMed

Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial.

2022

Journal of psychopharmacology (Oxford, England)

Guiraud J, Addolorato G, Antonelli M, Aubin HJ, de Bejczy A +28 more

Plain English
This study focused on a medication called sodium oxybate (SMO) to help people who are dependent on alcohol stay sober. In a large trial with 314 participants, those who took SMO experienced on average 43.1 more days of sobriety during the treatment period compared to those taking a placebo. The positive effects of sodium oxybate continued even after stopping the medication, and it was generally well-tolerated by patients. Who this helps: This benefits patients struggling with alcohol dependence.

PubMed

Diagnosis of COVID-19 in Patients with Negative Nasopharyngeal Swabs: Reliability of Radiological and Clinical Diagnosis and Accuracy Versus Serology.

2021

Diagnostics (Basel, Switzerland)

Mirijello A, Zarrelli M, Miscio G, de Matthaeis A, Piscitelli P +16 more

Plain English
This study looked at how well doctors and radiologists can diagnose COVID-19 in patients who tested negative for the virus with nasal swabs but still showed symptoms. Out of 84 patients, 63 were tested for antibodies, and 26 were found to have them, suggesting they had the virus despite the negative swabs. These findings are important because they show that doctors can make reliable COVID-19 diagnoses based on clinical signs and imaging even when test results aren't clear. Who this helps: This helps doctors and healthcare workers in diagnosing COVID-19 more accurately in symptomatic patients with negative tests.

PubMed

Low Sensitivity of Admission Lung US Compared to Chest CT for Diagnosis of Lung Involvement in a Cohort of 82 Patients with COVID-19 Pneumonia.

2021

Medicina (Kaunas, Lithuania)

Quarato CMI, Mirijello A, Lacedonia D, Russo R, Maggi MM +9 more

Plain English
This study examined how well lung ultrasound (LUS) can detect lung issues in patients with COVID-19 compared to chest CT scans, which are considered the standard for diagnosis. Researchers found that LUS correctly identified lung problems in only 52% of cases, with its accuracy varying significantly based on the severity of the lung involvement: it was just 8% for mild cases but improved to 100% for severe cases. This matters because relying solely on LUS could lead to missed diagnoses in many patients, highlighting the need for more comprehensive testing in emergency situations. Who this helps: This helps doctors and healthcare providers in emergency departments.

PubMed

Delta-Procalcitonin and Vitamin D Can Predict Mortality of Internal Medicine Patients with Microbiological Identified Sepsis.

2021

Medicina (Kaunas, Lithuania)

Tosoni A, Cossari A, Paratore M, Impagnatiello M, Passaro G +7 more

Plain English
This study looked at how two specific tests, Delta-Procalcitonin (Delta-PCT) and vitamin D levels, can help predict whether patients with sepsis in internal medicine will survive. Researchers found that patients with a significant drop in Delta-PCT levels after 48 to 96 hours had a much lower risk of dying in the next two to three months—only 0.12 times the risk if their levels dropped by more than 50%. Additionally, patients with severe vitamin D deficiency had nearly four times the risk of dying within 28 days compared to those with sufficient levels. Who this helps: This information is valuable for doctors treating hospitalized patients with sepsis, allowing them to assess the risk of mortality more effectively.

PubMed

More on SARS-CoV-2 Infection after Vaccination in Health Care Workers.

2021

The New England journal of medicine

Tosoni A, Mirijello A, Addolorato G

PubMed

A "Galactic" Chest X-ray.

2021

Diagnostics (Basel, Switzerland)

Carbonelli C, de Matthaeis A, Mirijello A, Di Micco C, Maiello E +2 more

Plain English
This study examined a specific pattern found in chest X-rays, called the "galaxy sign," in a 58-year-old woman with suspected COVID-19. The X-ray revealed signs of lung issues that indicate other possible serious conditions like sarcoidosis and tuberculosis, rather than just a viral infection. Recognizing this pattern can help doctors make quicker and more accurate diagnoses, leading to better treatment for patients. Who this helps: This helps doctors in diagnosing patients with respiratory issues more effectively.

PubMed

Neutropenic Enterocolitis and Sepsis: Towards the Definition of a Pathologic Profile.

2021

Medicina (Kaunas, Lithuania)

Bertozzi G, Maiese A, Passaro G, Tosoni A, Mirijello A +4 more

Plain English
This study looked at a serious condition called neutropenic enterocolitis (NE), which mainly affects people with weakened immune systems due to diseases like leukemia and other cancers. Researchers reviewed 19 studies and found that patients with NE can quickly get worse, leading to dangerous complications like sepsis, organ failure, and high mortality rates. Understanding the specific signs and symptoms associated with NE can help doctors recognize and treat it more effectively, improving patient outcomes. Who this helps: This helps doctors and healthcare providers working with cancer patients and those with weakened immune systems.

PubMed

Alcohol-related Liver Disease and sepsis.

2021

European review for medical and pharmacological sciences

Vassallo GA, Dionisi T, Tarli C, Augello G, Mirijello A +3 more

Plain English
This study looked at how sepsis, a serious infection, affects people with alcohol-related liver disease. Researchers found that patients with this condition have weakened immune systems and changes in gut bacteria, making them more prone to infections. Early and effective antibiotic treatment is crucial, as sepsis is particularly dangerous for these patients, and their chances of recovery are low. Who this helps: This helps patients with alcohol-related liver disease and their doctors.

PubMed

Lung Ultrasound in the Diagnosis of COVID-19 Pneumonia: Not Always and Not Only What Is COVID-19 "Glitters".

2021

Frontiers in medicine

Quarato CMI, Mirijello A, Maggi MM, Borelli C, Russo R +11 more

Plain English
This study looked at how well lung ultrasound (LUS) works to diagnose COVID-19 pneumonia compared to the more reliable chest CT scans. Out of 260 patients, LUS detected lung issues in only about 57% of cases, while the reliance on chest CT found COVID-19 pneumonia in nearly 91% of patients. The findings suggest that while LUS can be helpful, it's not enough on its own for accurate diagnosis and may lead to misclassifying other conditions as COVID-19 pneumonia. Who this helps: This research benefits doctors and healthcare providers working with COVID-19 patients.

PubMed

Transthoracic Ultrasound in Infectious Organizing Pneumonia: A Useful Guide for Percutaneous Needle Biopsy.

2021

Frontiers in medicine

Lacedonia D, Quarato CMI, Borelli C, Dimitri L, Graziano P +8 more

Plain English
This study examined the use of transthoracic ultrasound (TUS) to assist in taking biopsies from patients with infectious organizing pneumonia, a type of lung infection. Out of 36 patients, TUS was found to be less accurate than chest CT scans for identifying specific lung issues, but it was better at detecting fluid around the lungs. This matters because using TUS can help doctors safely perform biopsies, which can lead to accurate diagnoses and appropriate treatments for patients with lung infections. Who this helps: This helps doctors and patients needing lung biopsies for accurate diagnosis.

PubMed

Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey.

2021

International journal of clinical practice

Dionisi T, Sestito L, Tarli C, Antonelli M, Tosoni A +7 more

Plain English
The study examined stress and burnout levels in 51 doctors working in COVID wards at Gemelli Hospital in Italy over a month. It found that doctors from specialties other than internal medicine experienced significantly higher emotional exhaustion, while attending physicians generally reported less burnout than residents. This research highlights that the type of medical specialty and the level of training can affect burnout risk among healthcare workers during a pandemic. Who this helps: This benefits doctors and hospital administrators looking to support physician well-being.

PubMed

COVID-19 Pneumonia: The Great Ultrasonography Mimicker.

2021

Frontiers in medicine

Lacedonia D, Quarato CMI, Mirijello A, Trovato GM, Del Colle A +4 more

Plain English
The study looked at how lung ultrasounds (LUS) were being used to diagnose COVID-19 pneumonia, especially during the pandemic when CT scans were less accessible. It found that while LUS has become more popular because it's quick and easy to use, it can actually show results that look like COVID-19 pneumonia even when the patient doesn't have it, potentially leading to misdiagnoses. This is important because it highlights the need for careful interpretation of ultrasound results to avoid confusion with other diseases. Who this helps: This helps doctors in emergency departments make better decisions when diagnosing patients.

PubMed

Effectiveness and Safety of Transthoracic Ultrasound in Guiding Percutaneous Needle Biopsy in the Lung and Comparison vs. CT Scan in Assessing Morphology of Subpleural Consolidations.

2021

Diagnostics (Basel, Switzerland)

Sperandeo M, Maiello E, Graziano P, Simeone A, De Cosmo S +10 more

Plain English
This study looked at how well transthoracic ultrasound (TUS) can help doctors perform needle biopsies of lung lesions compared to traditional chest CT scans. Out of 762 patients who had TUS-guided biopsies, 82% had cancerous lesions, and the overall accuracy of the diagnosis was 93%. While TUS was effective and safe, it couldn't reliably distinguish between cancerous and non-cancerous lesions based on their appearance alone, which means CT scans are still important for accurate diagnosis. Who this helps: This research benefits patients with lung lesions by helping doctors choose the best methods for diagnosis.

PubMed

Pulmonary Artery Stump Thrombosis: To Treat or Not to Treat? The Question Is Still Open. Description of a Case and Review of the Literature.

2021

Frontiers in cardiovascular medicine

Mirijello A, Santoliquido M, Piscitelli P, Borelli C, Serviddio G +3 more

Plain English
This study looked at a condition called pulmonary artery stump thrombosis (PAST), which can happen after lung surgery. Researchers reported on a 59-year-old man who developed PAST four years after having part of his lung removed due to cancer. After starting treatment with blood thinners, his symptoms improved significantly, and follow-up scans showed that the clot almost completely resolved. Understanding and deciding how to treat PAST is important because it can help prevent serious complications. Who this helps: This helps patients recovering from lung surgery and their doctors in deciding the best treatment approach.

PubMed

Sepsis: New Challenges and Future Perspectives for an Evolving Disease-Precision Medicine Is the Way!

2021

Medicina (Kaunas, Lithuania)

Mirijello A, Tosoni A

Plain English
The study focuses on sepsis, a serious condition caused by infection that leads to life-threatening organ failure, and highlights new challenges and the need for tailored treatment approaches. It found that sepsis is still the top cause of hospital deaths worldwide, emphasizing the urgency for better strategies to manage it. This is important because improving the understanding and treatment of sepsis can save lives and reduce hospital fatalities. Who this helps: This benefits patients suffering from sepsis and healthcare providers involved in their treatment.

PubMed

Low eGFR Is a Strong Predictor of Worse Outcome in Hospitalized COVID-19 Patients.

2021

Journal of clinical medicine

Mirijello A, Piscitelli P, de Matthaeis A, Inglese M, D'Errico MM +9 more

Plain English
This study looked at how kidney function, specifically a measure called eGFR, affects the health of hospitalized COVID-19 patients. Out of 231 patients, 34% faced severe outcomes, including ICU admission or death, with a notably higher risk in those with low eGFR levels. Specifically, 27.7% of patients died, and low eGFR was linked to a 64% increase in risk for severe outcomes. This matters because identifying patients with poor kidney function can help ensure they receive urgent and appropriate medical care to improve their chances of recovery. Who this helps: Patients with COVID-19, especially those with pre-existing kidney conditions.

PubMed

Long-term blood pressure variability, incidence of hypertension and changes in renal function in type 2 diabetes.

2020

Journal of hypertension

Viazzi F, Russo E, Mirijello A, Fioretto P, Giorda C +9 more

Plain English
This study looked at how fluctuations in blood pressure over time affect patients with type 2 diabetes who have normal blood pressure. It found that patients with higher long-term blood pressure variability were significantly more likely to develop high blood pressure and worsening kidney issues; those with the highest fluctuations faced a 50% higher risk of hypertension. This matters because managing blood pressure variability could help prevent serious health problems for these patients. Who this helps: Patients with type 2 diabetes.

PubMed

Reduction of ADAMTS13 Levels Predicts Mortality in SARS-CoV-2 Patients.

2020

TH open : companion journal to thrombosis and haemostasis

Tiscia GL, Favuzzi G, De Laurenzo A, Cappucci F, Fischetti L +6 more

PubMed

Reduced glomerular filtration rate and prior cardiovascular event entail similar risk for coronary atherosclerotic burden.

2020

European review for medical and pharmacological sciences

Piscitelli P, Mangiacotti A, Marchese N, Greco EV, D'Errico MM +9 more

Plain English
This study looked at how kidney function and previous heart problems affect the risk of serious heart disease in 700 patients undergoing heart tests. Researchers found that patients with both kidney problems and a history of heart events had the highest risk for severe artery blockages, with a 3.35 times greater chance of having three-vessel disease compared to those with normal kidney function and no prior heart issues. This is important because it highlights that both kidney health and heart history are critical in assessing a patient's risk for serious heart conditions. Who this helps: This helps doctors in identifying and managing patients at higher risk for heart disease.

PubMed

New Strategies for Treatment of Sepsis.

2020

Medicina (Kaunas, Lithuania)

Mirijello A, Tosoni A, On Behalf Of The Internal Medicine Sepsis Study Group

Plain English
This study explored new ways to treat sepsis, a severe condition that occurs when the body has an extreme response to infection, leading to organ damage and often death. It found that rapid recognition of sepsis and standardized treatment can significantly improve patient outcomes. The research emphasizes the importance of using both new and traditional methods of treatment across different hospital departments to adapt to patients' needs, which is crucial since sepsis causes about half of all hospital deaths. Who this helps: This benefits patients with sepsis and their healthcare providers.

PubMed

Venous thromboembolism during mycoplasma pneumoniae infection: case report and review of the literature.

2020

European review for medical and pharmacological sciences

Mirijello A, La Marca A, D'Errico MM, Curci S, Vendemiale G +2 more

Plain English
This study looked at a 45-year-old man who developed a blood clot in his lungs after being infected with Mycoplasma pneumoniae, typically a mild infection causing respiratory symptoms. Infection with this bacteria can sometimes lead to serious complications like venous thromboembolism, and in this case, the man tested positive for antiphospholipid antibodies, which are linked to increased clotting risk. Understanding this connection is important because it can help doctors identify and manage the risk of blood clots in patients with Mycoplasma pneumoniae infection. Who this helps: This helps doctors and patients by improving awareness of potential serious complications related to a common respiratory infection.

PubMed

Wernicke's Encephalopathy in Alcohol Use Disorder Patients after Liver Transplantation: A Case Series and Review of Literature.

2020

Journal of clinical medicine

Vassallo GA, Mirijello A, Dionisi T, Tarli C, Augello G +3 more

Plain English
This study looked at three patients with alcohol use disorder who developed a serious brain condition called Wernicke's encephalopathy after undergoing liver transplantation. All patients showed confusion and delirium, but after receiving thiamine (a vitamin) quickly, they improved significantly within 3-4 days. This is important because it suggests that giving thiamine before and after liver surgery could help prevent this dangerous condition in patients with alcohol use disorder. Who this helps: This helps patients with alcohol use disorder undergoing liver transplantation.

PubMed

Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.

2020

Journal of the American College of Cardiology

Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E +65 more

Plain English
This research paper examined the global impact of cardiovascular diseases (CVDs), like heart disease and stroke, from 1990 to 2019. The study found that the number of people with CVD nearly doubled from 271 million in 1990 to 523 million in 2019, while deaths from CVD increased from 12.1 million to 18.6 million. This rise in disease burden highlights an urgent need for effective health policies to prevent these conditions and save lives, especially as CVD remains the top cause of death worldwide. Who this helps: This information benefits patients, healthcare providers, and policymakers focused on reducing heart disease and improving public health.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.